PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access

Author(s):

Robert O'Brien, RPh,Diana Brixner, PhD

In their closing remarks, the panel shares their view on the future of prescription digital therapeutics and the prospects for the widespread adoption and implementation of these therapeutics in health care systems.

EP: 1.Differentiating PDTs from Wellness Apps and Evaluating Efficacy

EP: 2.Payer Needs and Strategies for Evaluating and Covering PDTs

EP: 3.Payers Review Process and Effective Strategies for PDT Coverage

EP: 4.Stakeholder Involvement and Evidence Requirements for PDT Coverage Decisions

EP: 5.Dawn of the Age of Adopting PDTs

EP: 6.Identifying the Most Impactful Disease Areas and Patient Populations for PDTs

EP: 7.Evolving Commercialization and Distribution Models for PDTs

EP: 8.Promoting Appropriate PDT Prescribing Through Provider Education and Support

EP: 9.Optimizing Provider Education, Utilization Monitoring, and Value-Based Contracts for PDTs

EP: 10.Optimizing Benefit Design and Implementation for Improved PDT Access

Now Viewing

EP: 11.PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access

Video content above is prompted by the following questions:

How can payers work with providers to establish protocols for appropriate PDT prescribing and monitoring efficacy?
What opportunities exist for collaborative demonstration projects across payers, providers, manufacturers, and other stakeholders to generate evidence on optimal implementation strategies?
How might PDTs potentially help mitigate or reduce healthcare disparities and inequities in access to treatment or health outcomes across different populations?
How important is it that Congress pass the Access to Prescription Digital Therapeutics Actas you consider the long-term value PDTs can have on improving care to patients?